Newsletter

Cancer

Latest
A packet of medication resting on a surface.

Oncolytics Biotech: Phase 1 Trial Data of Pelareorep for Colorectal Cancer

A collection of pills forming the shape of an arrow.

Opdivo and Yervoy Improve Survival in Metastatic NSC Lung Cancer

A micrograph of nodular basal cell carcinoma demonstrating a cleft.

Surface Oncology, Merck Partners for Phase 1 Trial of anti-CD39 SRF617

A pink breast cancer awareness ribbon resting on a table.

Adaptimmune: iT SPEAR T Cells Successfully Produced, Fight Cancer

A medical monitor showing the vital signs of a patient.

NantKwest: Phase 2 Trial of NK Cell Pancreatic Cancer Immunotherapy

Researchers from the Technical University of Munich including Dr. Dirk Busch, Dr. Kilian Schober, and Dr. Florian Voit. Their team recently published their research on the T cell response to chronic infection in the journal Nature Immunology.

T Cell Response to Chronic Infection Found to Favor Low-Affinity TCRs

A schematic of multiple myeloma cells showing the cancerous plasma cells secreting M proteins.

Melflufen Shows Efficacy for Relapsed or Refractory Multiple Myeloma

A scientist reviewing the contents of a test tube.

Biocept Reports Publication Further Validating Cancer Biopsy Platform

Novel Engineered Nanoparticles Enhance Targeted Immunotherapy for Solid Tumors

New Insights into Tumor-Associated Monocytes and Macrophages Show Promise for the...

123Page 2 of 3

Featured Articles

Contact

Connect

Follow Us

ImmunoFrontiers © 2019-2021. All Rights Reserved. We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.

error: Content is protected.